This document presents the results of a study aiming to develop selective inhibitors of BACE2 using computer-aided drug design. BACE2 is homologous to BACE1 but is predominantly expressed in peripheral tissues and may serve as an alternative protease in APP processing. The study validated docking programs for reproducing binding poses of BACE1 and BACE2 inhibitors and evaluated scoring functions for virtual screening. A BACE2 homology model produced better virtual screening results than crystal structures. Future work will involve virtual screening larger libraries and designing new scaffolds for selective BACE2 inhibition.